(KERX, SGYP, ADUS) Stock Report from CRWEFinance.com

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), announced its results for the fourth quarter and year ended December 31, 2011. At December 31, 2011, the Company had cash, cash equivalents, interest receivable, and investment securities of $39.5 million, as compared to $28.5 million at December 31, 2010. The net loss for the fourth quarter ended December 31, 2011 was $8.4 million, or $0.12 per share, compared to a net loss of $5.3 million, or $0.09 per share, for the comparable quarter in 2010, representing an increase in net loss of $3.1 million. The change in net loss in the fourth quarter of 2011, as compared to the fourth quarter of 2010, was primarily attributable to a $2.5 million increase in other research and development expenses, principally related to the KRX-0401 (perifosine) and Zerenex Phase 3 clinical programs. The net loss for the fourth quarter ended December 31, 2011, included $0.5 million of non-cash compensation expense related to equity incentive grants. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment cancer and renal disease. ********************************************* Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP) a developer of new drugs to treat gastrointestinal disorders and diseases, announced that its President and CEO, Gary S. Jacob, Ph.D, will present at the 32nd Annual Cowen and Company Health Care Conference. Dr. Jacob’s presentation will be given on Monday, March 5th, 2012 at 4:10 p.m. EST. Synergy Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal disorders and diseases. ********************************************* Addus HomeCare Corporation (Nasdaq:ADUS), a comprehensive provider of home-based social and medical services focused primarily on the dual eligible population, announced its financial results for the three months and year ended December 31, 2011. Total net service revenues for the fourth quarter of 2011 were $68.6 million, a 2.1% decrease compared to $70.1 million in the prior year quarter. Net income for the fourth quarter was $2.5 million, or $0.23 per diluted share, compared to $1.5 million or $0.14 per diluted share, in the prior year quarter. Addus HomeCare Corporation provides a range of social and medical services to individuals in the home. ******************************************************************** Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.